BP4200: Recombinant Dr. Nuclease (Benzonase Nuclease Alternative)
Source: E. coli-derived.
Specific activity: ≥1.75 x 10^6 U/mg. One unit of Dr. Nuclease corresponds approximately to the required amount of enzyme to digest 37 μg of DNA in the reaction buffer, 50 mM Tris-HCl, pH 8.0, 1 mM MgCl2, for 30 minutes at 37°C.
Purity >98% by SDS-PAGE.BP4200-GMP: Recombinant Dr. Nuclease (Benzonase Nuclease Alternative), GMP Grade
Source: E. coli-derived.
Predicted molecular mass: ~28 kDa.
Specific activity: ≥1.75 x 10^6 U/mg. One unit of Dr. Nuclease is defined as the amount of enzyme required to produce a change in absorbance at 260nm of 1.0 in the time of 30 minutes, under optimum conditions with excess substrate.
Purity: ≥95% by SDS-PAGE and ≥99% by SEC-HPLC. It does not contain any antimicrobial preservatives or protein stabilizers except glycerol (of synthetic origin).
Formulation: 0.2 μM filtered solution (250 units/ul) of 20 mM Tris-HCl, pH 8.0, 2 mM MgCl2, 2 mM NaCl, 50% Glycerol.
Endotoxin level: ≤0.01 EU/1000 units following 2020 ChP 1143 USP <85>.
Protease activity: No detectable protease activity using casein as substrate.
Residual host cell protein: ≤10.0 ppm by ELISA.
Mycoplasma: negative by qPCR method.
Bioburden: negative following 2020 ChP 1105 USP <61>.
Residual heavy metal: ≤10.0 ppm following 2020 ChP 0821 USP <32>.BP004000: Recombinant Human Laminin 521 Protein (Research Grade)
Source: mammalian cell-derived.
Applications: for a wide range of cells, from human iPSCs and MSCs to most anchorage-dependent progenitor cell types; compatible with a variety of feeder-free stem cell culture media on the market; maintaining the homogeneous growth and karyotype stability of stem cells.
Purity: >95% by SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 10 EU/mg of protein as determined by LAL method.BP004000.CG: Recombinant Human Laminin 521 Protein (Preclinical Grade)
Source: mammalian cell-derived.
Applications: for a wide range of cells, from human iPSCs and MSCs to most anchorage-dependent progenitor cell types; compatible with a variety of feeder-free stem cell culture media on the market; maintaining the homogeneous growth and karyotype stability of stem cells.
Purity: >95% by SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 10 EU/mg of protein as determined by LAL method.
Animal component free: No materials of animal origin; free of TSE/BSE.BP003056: Recombinant SARS-CoV-2 Spike S1-Fc-Avi Protein (S Protein S1 Subunit)
Source: mammalian cells.
Activity: Immobilized recombinant human ACE2, His Tag at 0.5 ug/ml (100 ul/well). Dose response curve for the recombinant SARS-CoV-2 Spike S1-Fc-Avi protein with the EC50 of 0.1 ug/ml determined by ELISA.
Purity: > 95% by PAGE under reduced condition, and SEC-HPLC.BP003050: Recombinant SARS-CoV-2 Spike RBD-Fc-Avi (S Protein)
Source: mammalian cells.
Purity: > 95% by PAGE under reduced condition, and SEC-HPLC.BP003053: Recombinant SARS-CoV-2 Nucleocapsid Protein-His-Avi (NP Protein, N Protein)
Source: E.coli.
Purity: > 95% by PAGE under reduced condition.BP003052: Recombinant SARS-CoV-2 Spike RBD-His-Avi
Source: mammalian cells.
Purity: > 95% by PAGE under reduced condition, and SEC-HPLC.BP003057: Recombinant SARS-CoV-2 Spike S-Fc Protein
Source: HEK 293 cells.
Purity: > 95% by PAGE under reduced condition, and SEC-HPLC.BP003054: Recombinant SARS-CoV-2 Spike S1-His-Avi Protein (Spike Protein S1 Subunit)
Source: mammalian cells.
Activity: Immobilized recombinant SARS-CoV-2 Spike S1-His-Avi protein at 0.5 ug/ml (100 ul/well). Dose response curve for the biotinylated recombinant human ACE2-His fusion protein with the EC50 of 0.2 ug/ml determined by ELISA.
Purity: > 95% by PAGE under reduced condition, and SEC-HPLC.BP003062: Recombinant Human ACE2-Fc-Avi Protein (rhACE2-Fc)
Source: mammalian cells.
Activity: Immobilized biotinylated recombinant SARS-CoV-2 Spike S RBD with the His Tag at 1 ug/ml (100 ul/well). Dose response curve for rhACE2-Fc fusion protein with the EC50 of 81 ng/ml determined by ELISA.
Purity: > 95% by PAGE under reduced condition, and SEC-HPLC.BP003082: Recombinant Human CD319 / CRACC / SLAMF7 Protein
Source: mammalian cells.
Purity: > 95% by Bis-Tris PAGE and HPLC.